Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling

Area of Science:

• Dermatology
• Oncology
• Molecular Biology

Background:

• Cutaneous squamous cell carcinoma (cSCC) is a prevalent and increasing skin cancer in fair-skinned individuals.
• The molecular mechanisms driving cSCC development from premalignant lesions remain unclear.
• Understanding these molecular events is critical for advancing therapeutic strategies.

Purpose of the Study:

• To identify key molecular differences between actinic keratoses (AKs) and invasive cSCC.
• To elucidate the genetic alterations underlying the progression from AK to cSCC.
• To explore potential therapeutic targets for cSCC prevention and treatment.

Main Methods:

• Transcriptome profiling using Affymetrix HGU133 Plus 2.0 microarrays.
• Laser capture microdissection to isolate cells from 30 cSCC and 10 AK samples.
• Gene set enrichment analysis to identify key biological pathways involved.

Main Results:

• A core set of 196 differentially expressed genes was identified between AK and cSCC.
• These genes are involved in epidermal differentiation, cell migration, cell-cycle regulation, and metabolism.
• The mitogen activated protein kinase (MAPK) pathway was significantly upregulated in cSCC compared to AK.

Conclusions:

• The MAPK pathway plays a pivotal role in the transition from AK to cSCC, suggesting it as a potential target for prevention.
• Transcriptome differences between cSCC subtypes highlight the need for tailored therapeutic approaches.
• Further research into MAPK signaling could lead to novel targeted therapies for cSCC.